p53 Protein Overexpression: A Strong Prognostic Factor in Uterine Papillary Serous Carcinoma

By Bancher-Todesca D.   Gitsch G.   Williams K.E.   Kohlberger P.   Neunteufel W.   Obermair A.   Heinze G.   Breitenecker G.   Hacker N.F.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 59-63

Elsevier

Access to resources Recommend Favorite

Epidemiologic and Surgicopathologic Findings of Papillary Serous and Clear Cell Endometrial Cancers When Compared to Endometrioid Carcinoma

By Cirisano F.D.   Robboy S.J.   Dodge R.K.   Bentley R.C.   Krigman H.R.   Synan I.S.   Soper J.T.   Clarke-Pearson D.L.  

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 385-394

Elsevier

Access to resources Recommend Favorite

Distinct subtypes of serous ovarian carcinoma identified by p53 determination*

By Lassus H.   Leminen A.   Lundin J.   Lehtovirta P.   Butzow R.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 504-512

Elsevier

Access to resources Recommend Favorite

Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix*

By Grace V.M.B.   Shalini J.V.   lekha T.T.S.   Devaraj S.N.   Devaraj H.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 51-58

Elsevier

Access to resources Recommend Favorite

The Outcome of Stage I-II Clinically and Surgically Staged Papillary Serous and Clear Cell Endometrial Cancers When Compared with Endometrioid Carcinoma

By Cirisano F.D.   Robboy S.J.   Dodge R.K.   Bentley R.C.   Krigman H.R.   Synan I.S.   Soper J.T.   Clarke-Pearson D.L.  

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 55-65

Elsevier

Access to resources Recommend Favorite